These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6341002)

  • 21. Interaction of human natural killer cells with plasmodium-infected erythrocytes.
    Saxena QB; Biswas S; Sharma VP
    Exp Parasitol; 1989 Oct; 69(3):300-2. PubMed ID: 2676579
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasmodium gallinaceum as antigen in immunofluorescence antibody studies.
    Kielmann A; Weiss N
    Acta Trop; 1968; 25(2):185-7. PubMed ID: 4386698
    [No Abstract]   [Full Text] [Related]  

  • 23. [Can malaria be eradicated by vaccination?].
    Stürchler D
    Schweiz Rundsch Med Prax; 1987 Sep; 76(36):975-80. PubMed ID: 3310179
    [No Abstract]   [Full Text] [Related]  

  • 24. Opsonizing and agglutinating antibodies against Plasmodium falciparum schizont-infected erythrocytes in Gambian sera.
    Abdalla SH
    Trans R Soc Trop Med Hyg; 1987; 81(2):214-8. PubMed ID: 3303477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy.
    Finney CA; Ayi K; Wasmuth JD; Sheth PM; Kaul R; Loutfy MR; Kain KC; Serghides L
    AIDS; 2013 Jan; 27(3):325-35. PubMed ID: 23291537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malarial immunity: current trends and prospects.
    McGregor IA
    Ann Trop Med Parasitol; 1987 Oct; 81(5):647-56. PubMed ID: 3331254
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of the spleen on the expression of surface antigens on parasitized erythrocytes.
    Barnwell JW; Howard RJ; Miller LH
    Ciba Found Symp; 1983; 94():117-36. PubMed ID: 6340998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of crisis form factor in subjects immune to Plasmodium falciparum in The Gambia, West Africa.
    Marsh K; Otoo L; Greenwood BM
    Trans R Soc Trop Med Hyg; 1987; 81(3):514-5. PubMed ID: 3318027
    [No Abstract]   [Full Text] [Related]  

  • 29. Localization of the ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum in merozoites and ring-infected erythrocytes.
    Brown GV; Culvenor JG; Crewther PE; Bianco AE; Coppel RL; Saint RB; Stahl HD; Kemp DJ; Anders RF
    J Exp Med; 1985 Aug; 162(2):774-9. PubMed ID: 3894564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Duffy blood group and resistance to Plasmodium vivax in Honduras.
    Spencer HC; Miller LH; Collins WE; Knud-Hansen C; McGinnis MH; Shiroishi T; Lobos RA; Feldman RA
    Am J Trop Med Hyg; 1978 Jul; 27(4):664-70. PubMed ID: 356634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immunity to malaria caused by Plasmodium falciparum.
    Smith TG; Ayi K; Serghides L; Mcallister CD; Kain KC
    Clin Invest Med; 2002 Dec; 25(6):262-72. PubMed ID: 12516999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targets of protective antibodies to malaria during pregnancy.
    Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
    J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-I anti-erythrocyte auto-immunization in malaria].
    Penalba C; Simonneau M; Autran B; Bouvet Koskas E; Vroclans M; Vachon F; Coulaud JP; Saimot AG
    Bull Soc Pathol Exot Filiales; 1984; 77(4):469-80. PubMed ID: 6391711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous in vitro cultivation of Plasmodium falciparum and its applications in immunology of malaria.
    Sivaraman CA
    J Commun Dis; 1985; 17(1 Suppl):23-30. PubMed ID: 3913697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Resistance in malaria].
    Luca M
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(1):52, 76. PubMed ID: 6400404
    [No Abstract]   [Full Text] [Related]  

  • 39. Estimation of antimalarial antibody by radioimmunoassay.
    Stutz DR; McAlister RO; Diggs CL
    J Parasitol; 1974 Jun; 60(3):539-42. PubMed ID: 4599928
    [No Abstract]   [Full Text] [Related]  

  • 40. Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen.
    Hommel M; David PH; Oligino LD
    J Exp Med; 1983 Apr; 157(4):1137-48. PubMed ID: 6187885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.